148 related articles for article (PubMed ID: 16460684)
1. Alpha-lipoic acid exhibits anti-amyloidogenicity for beta-amyloid fibrils in vitro.
Ono K; Hirohata M; Yamada M
Biochem Biophys Res Commun; 2006 Mar; 341(4):1046-52. PubMed ID: 16460684
[TBL] [Abstract][Full Text] [Related]
2. Preformed beta-amyloid fibrils are destabilized by coenzyme Q10 in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Biochem Biophys Res Commun; 2005 Apr; 330(1):111-6. PubMed ID: 15781239
[TBL] [Abstract][Full Text] [Related]
3. Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro.
Ono K; Hirohata M; Yamada M
Biochem Biophys Res Commun; 2005 Oct; 336(2):444-9. PubMed ID: 16153607
[TBL] [Abstract][Full Text] [Related]
4. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
J Neurosci Res; 2004 Mar; 75(6):742-50. PubMed ID: 14994335
[TBL] [Abstract][Full Text] [Related]
5. Anti-Parkinsonian agents have anti-amyloidogenic activity for Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Neurochem Int; 2006 Mar; 48(4):275-85. PubMed ID: 16343694
[TBL] [Abstract][Full Text] [Related]
6. Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fibrils in vitro.
Morinaga A; Hirohata M; Ono K; Yamada M
Biochem Biophys Res Commun; 2007 Aug; 359(3):697-702. PubMed ID: 17559807
[TBL] [Abstract][Full Text] [Related]
7. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Biochim Biophys Acta; 2004 Nov; 1690(3):193-202. PubMed ID: 15511626
[TBL] [Abstract][Full Text] [Related]
8. Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro.
Ono K; Yoshiike Y; Takashima A; Hasegawa K; Naiki H; Yamada M
Exp Neurol; 2004 Oct; 189(2):380-92. PubMed ID: 15380488
[TBL] [Abstract][Full Text] [Related]
9. Blood-borne factors inhibit Alzheimer's beta-amyloid fibril formation in vitro.
Ono K; Noguchi-Shinohara M; Samuraki M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
Exp Neurol; 2006 Nov; 202(1):125-32. PubMed ID: 16806179
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Hirohata M; Ono K; Naiki H; Yamada M
Neuropharmacology; 2005 Dec; 49(7):1088-99. PubMed ID: 16125740
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro.
Ono K; Noguchi M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
Neurobiol Dis; 2005 Nov; 20(2):233-40. PubMed ID: 16242632
[TBL] [Abstract][Full Text] [Related]
12. Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Yoshiike Y; Takashima A; Yamada M; Naiki H
J Neurochem; 2002 May; 81(3):434-40. PubMed ID: 12065652
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro.
Ono K; Yamada M
J Neurochem; 2006 Apr; 97(1):105-15. PubMed ID: 16524383
[TBL] [Abstract][Full Text] [Related]
14. The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure.
Hirohata M; Hasegawa K; Tsutsumi-Yasuhara S; Ohhashi Y; Ookoshi T; Ono K; Yamada M; Naiki H
Biochemistry; 2007 Feb; 46(7):1888-99. PubMed ID: 17253770
[TBL] [Abstract][Full Text] [Related]
15. Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's beta-amyloid proteins.
Fujiwara H; Iwasaki K; Furukawa K; Seki T; He M; Maruyama M; Tomita N; Kudo Y; Higuchi M; Saido TC; Maeda S; Takashima A; Hara M; Ohizumi Y; Arai H
J Neurosci Res; 2006 Aug; 84(2):427-33. PubMed ID: 16676329
[TBL] [Abstract][Full Text] [Related]
16. Nordihydroguaiaretic acid does not disaggregate beta-amyloid(1-40) protofibrils but does inhibit growth arising from direct protofibril association.
Moss MA; Varvel NH; Nichols MR; Reed DK; Rosenberry TL
Mol Pharmacol; 2004 Sep; 66(3):592-600. PubMed ID: 15322251
[TBL] [Abstract][Full Text] [Related]
17. Catechol derivatives inhibit the fibril formation of amyloid-beta peptides.
Huong VT; Shimanouchi T; Shimauchi N; Yagi H; Umakoshi H; Goto Y; Kuboi R
J Biosci Bioeng; 2010 Jun; 109(6):629-34. PubMed ID: 20471605
[TBL] [Abstract][Full Text] [Related]
18. Anti-fibrillogenic and fibril-destabilizing activities of anti-Parkinsonian agents for alpha-synuclein fibrils in vitro.
Ono K; Hirohata M; Yamada M
J Neurosci Res; 2007 May; 85(7):1547-57. PubMed ID: 17387689
[TBL] [Abstract][Full Text] [Related]
19. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease.
Ono K; Yoshiike Y; Takashima A; Hasegawa K; Naiki H; Yamada M
J Neurochem; 2003 Oct; 87(1):172-81. PubMed ID: 12969264
[TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
